Evidence map›Paper›PMID 23888319›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1.

Zhen-Cai Li, Li-Ming Zhang, Hai-Bin Wang, Jun-Xun Ma, Jun-Zhong Sun

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Analysis of Promoter Methylation of the BovineAnimals : an open access journal from MDPI · 2023
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Plant Polyphenols as Chemopreventive Agents for Lung Cancer.International journal of molecular sciences · 2016
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.International journal of clinical and experimental medicine · 2015
    Article
  15. Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.International journal of clinical and experimental medicine · 2015
    Article
  16. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.Clinical, cosmetic and investigational dermatology · 2015
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zhen-Cai LiDepartment of Ultrasound, The First Affiliated Hospital, General Hospital of Chinese PLA, Beijing, 100048, China.
Li-Ming Zhang
Hai-Bin Wang
Jun-Xun Ma
Jun-Zhong Sun
First Affiliated Hospital of Chinese PLA General Hospital · CNChinese People 's Liberation Army No. 85 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent population studies provide clues that the use of curcumin may be associated with reduced incidence and improved prognosis of certain cancers. In the present study, we demonstrated that curcumin acted as a growth inhibitor for lung cancer cells. Our results found that curcumin inhibited cell proliferation, which was associated with upregulation of the cyclin-dependent kinase inhibitors, p27 and p21, and downregulation of cyclin D1. In addition, we showed that curcumin induced the expression of forkhead box protein O1 (FOXO1) through activation of extracellular signal-regulated kinase 1/2 signaling. These findings provide evidence for a mechanism that may contribute to the antineoplastic effects of curcumin and justify further work to explore potential roles for activators of FOXO1 in the prevention and treatment of lung cancer.

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationCurcuminCyclin D1Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Disease ProgressionDose-Response Relationship, DrugForkhead Box Protein O1Forkhead Transcription FactorsHumansLung NeoplasmsMAP Kinase Signaling SystemNeoplasm MetastasisAntineoplastic AgentsCurcuminCyclin D1Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Forkhead Box Protein O1Forkhead Transcription FactorsFOXO1 protein, human

Identifiers

PMID23888319
OpenAlexW1966872952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.